Breaking News, Latest Philippines Headlines, World, Entertainment, Politics, Weather & Video News
by Catherine Triomphe Agence France-Presse NEW YORK, United States (AFP) — Martin Shkreli, once dubbed the most hated man in America for ratcheting up the price of an HIV drug, was sentenced to seven years in prison Friday on charges of defrauding investors. The disgraced former pharmaceutical executive and hedge fund manager was convicted in August of conspiracy to commit securities fraud and two counts of securities fraud. Shkreli, who once led Turing Pharmaceuticals, became […]
by Leila MACOR Agence France-Presse MIAMI, United States (AFP) — A little known pharmaceutical company in Florida has found itself in the eye of a storm following disclosures it raised the price of an old drug used to fight brain tumors by 1,400 percent, from $50 a pill to more than $700. NextSource Biotechnology in 2013 bought the license for the drug Lomustine from Bristol-Myers Squibb, which sold a 100-milligram pill of the substance for […]
WASHINGTON, United States (AFP) — US regulators have approved the first pill that contains a digital tracking sensor to alert doctors and caregivers as to whether a patient is taking a medication as scheduled. The pill, called Abilify MyCite (aripiprazole tablets with sensor), is designed for patients with schizophrenia, bipolar disorder and depression, according to the US Food and Drug Administration. A patient ingests the pill, and a sensor inside the pill activates when it […]
NEW YORK, United States (AFP) — Prosecutors announced Tuesday they added 12 more companies and two executives as targets in a wide-ranging antitrust investigation that charges generic drug manufacturers fixed drug prices. The suit, which was filed in December and is now supported by prosecutors from 45 US states, alleges a broad conspiracy by Mylan Pharmaceuticals, Teva Pharmaceuticals and others to divvy up markets and set prices to boost profits at consumer’s expense. On Tuesday, […]
FRANKFURT, Germany (AFP) — The pharmaceuticals sector is facing an intensive period of mergers and acquisitions in the coming years, even if US firms Pfizer and Allergan recently failed to tie the knot, the corporate consultancy firm EY said Monday. “We’re going to see a high level of investments and divestments in the pharmaceuticals sector in the coming years,” said Gerd Stuerz, analyst at EY. In April, Pfizer and Allergan called off a $160-billion (144-billion-euro) tie-up […]
